Related Experiment Video
Updated: Nov 26, 2025

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
Published on: April 7, 2015
Bacille Calmette-Guérin inoculation site changes and cardiac complications in patients with Kawasaki disease
Haruki Takikawa1, Ryusuke Ae2, Yuri Matsubara1
1Division of Public Health, Center for Community Medicine, Jichi Medical University, Shimotsuke, Tochigi, Japan.
Insights
Redness and crusting at the bacille Calmette-Guérin inoculation site (BCGitis) during Kawasaki disease (KD) is not an independent risk factor for cardiac complications. Prompt intravenous immunoglobulin (IVIG) treatment appears to be a confounding factor, potentially preventing these complications.
Area of Science:
- Pediatrics
- Infectious Diseases
- Cardiology
Background:
- Kawasaki disease (KD) is a critical pediatric illness.
- Cardiac complications are a major concern in KD patients.
- Bacille Calmette-Guérin inoculation site inflammation (BCGitis) is observed in some KD cases.
Purpose of the Study:
- To determine if BCGitis is an independent risk factor for cardiac complications in Kawasaki disease.
- To investigate the relationship between BCGitis and the development of cardiac sequelae in KD patients.
Main Methods:
- Retrospective cohort study utilizing nationwide Kawasaki disease survey data from Japan (2005-2006).
- Inclusion of 17,181 pediatric patients diagnosed with KD.
- Analysis of BCGitis presence and its association with cardiac complications, adjusting for treatment factors.
Main Results:
- BCGitis was present in 44% of KD patients.
- Initially, BCGitis appeared associated with fewer cardiac complications (crude OR 0.81).
- After adjusting for early intravenous immunoglobulin (IVIG) treatment, BCGitis was not an independent risk factor (adjusted OR 0.89).
Conclusions:
- BCGitis is not an independent predictor of cardiac complications in Kawasaki disease.
- Early administration of IVIG is a significant factor, potentially confounding the association with BCGitis.
- Prompt treatment may mitigate the risk of cardiac complications, regardless of BCGitis presence.
Objective:
To investigate whether redness and crusting at the bacille Calmette-Guérin inoculation site (BCGitis), identified during acute illness owing to Kawasaki disease (KD), is an independent risk factor for development of cardiac complications.
Design:
Retrospective cohort study using data from the nationwide KD survey in Japan.
Setting:
Survey respondents included hospitals specialising in paediatrics and hospitals with ≥100 beds and a paediatric department throughout Japan.
Patients:
We included 17 181 patients with KD across Japan during 2005-2006.
Main Outcome Measures:
BCGitis and cardiac complications resulting from KD.
Results:
BCGitis was identified in 7549 (44%) patients with KD. Compared with patients without BCGitis, those with BCGitis were younger, more likely to be male, less likely to have recurrent status and visited a hospital and underwent initial intravenous immunoglobulin (IVIG) treatment earlier after KD onset. In the unadjusted model, patients with BCGitis were significantly less likely to have cardiac complications (crude OR 0.81, 95% CI 0.71 to 0.92). However, after including treatment factors (days of illness at initial IVIG and treatment responsiveness) in the adjusted model, the association was no longer significant (adjusted OR 0.89, 95% CI 0.77 to 1.03), indicating that BCGitis was not an independent factor associated with cardiac complication and might be confounded by treatment factors.
Conclusions:
BCGitis was identified in comparatively early illness stages of KD. Our findings indicated that BCGitis was not an independent factor associated with developing cardiac complications but was confounded by prompt initial IVIG administration, which might result in successful treatment and prevention of cardiac complications.
More Related Videos
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Endocarditis II: Clinical Features of Infective Endocarditis
Myocarditis III: Medical Management
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management
Myocarditis I: Introduction

